Swedish Registry Study Links Pre-Pregnancy Quadrivalent HPV Vaccination to Reduced Preterm Birth Odds

Researchers matched cases of adverse outcomes to up to 10 controls by maternal age and conception year, adjusting for smoking, BMI, assisted reproduction, income, education, and country of birth. Quadrivalent HPV vaccination (15% coverage) showed statistically significant associations with reduced preterm birth, spontaneous preterm birth, preterm prelabor rupture of membranes, and severe fetal growth restriction; absolute risk differences were not reported. The study design cannot distinguish direct viral prevention from unmeasured behavioral differences between vaccinated and unvaccinated women.

HPV infection and excisional cervical treatments are established risk factors for preterm delivery via inflammation and cervical insufficiency. Earlier vaccination likely interrupts persistent high-risk HPV acquisition during peak sexual activity years, aligning with prior observational data from Denmark and Australia showing similar signals. However, the Swedish analysis adds granularity by stratifying on age at vaccination and examining rare outcomes such as stillbirth within a single high-quality registry system.

Public health programs targeting adolescents could yield dual benefits against cervical cancer and neonatal morbidity, yet residual confounding by healthcare-seeking behavior remains plausible. Next steps require either a large pragmatic trial randomizing catch-up vaccination timing or pooled individual-level data across Nordic registries to test mediation by documented HPV clearance.